Integrated substance use and prenatal care delivery in the era of COVID-19
The COVID-19 pandemic has directly impacted integrated substance use and prenatal care delivery in the United States and has driven a rapid transformation from in-person prenatal care to a hybrid telemedicine care model. Additionally, changes in regulations for take home dosing for methadone treatment for opioid use disorder due to COVID-19 have impacted pregnant and postpartum women. We review the literature on prenatal care models and discuss our experience with integrated substance use and prenatal care delivery during COVID-19 at New England ’s largest safety net hospital and national leader in substance use care.
Source: Journal of Substance Abuse Treatment - Category: Addiction Authors: Elizabeth W. Patton, Kelley Saia, Michael D. Stein Source Type: research
More News: Addiction | COVID-19 | Hospitals | Methadone | Pandemics | Pregnancy | Substance Abuse | Substance Abuse Disorders | USA Health | Women